Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Boelaert, JR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 70 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Boelaert, JR; Appelberg, R; Gomes, MS; Blasi, E; Mazzolla, R; Grosset, J; Lounis, N; Soteriadou, K; Thiakaki, M; Taramelli, D; Tognazioli, C
      Experimental results on chloroquine and AIDS-related opportunistic infections

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Boelaert, JR
      Second International Conference on HIV and Iron

      JOURNAL OF CLINICAL VIROLOGY
    3. Gordeuk, VR; Delanghe, JR; Langlois, MR; Boelaert, JR
      Iron status and the outcome of HIV infection: an overview

      JOURNAL OF CLINICAL VIROLOGY
    4. Gomes, MS; Boelaert, JR; Appelberg, R
      Role of iron in experimental Mycobacterium avium infection

      JOURNAL OF CLINICAL VIROLOGY
    5. Lounis, N; Truffot-Pernot, C; Grosset, J; Gordeuk, VR; Boelaert, JR
      Iron and Mycobacterium tuberculosis infection

      JOURNAL OF CLINICAL VIROLOGY
    6. Savarino, A; Gennero, L; Sperber, K; Boelaert, JR
      The anti-HIV-1 activity of chloroquine

      JOURNAL OF CLINICAL VIROLOGY
    7. Boelaert, JR; Piette, J; Sperber, K
      The potential place of chloroquine in the treatment of HIV-1-infected patients

      JOURNAL OF CLINICAL VIROLOGY
    8. Simonart, T; Degraef, C; Stordeur, P; Noel, JC; Mosselmans, R; Van Vooren, JP; Parent, D; Boelaert, JR; Heenen, M; Galand, P
      Iron induces Bcl-2 expression in human dermal microvascular endothelial cells

      FREE RADICAL RESEARCH
    9. Weinberg, GA; Friis, H; Boelaert, JR; Weinberg, ED
      Iron status and the severity of HIV infection in pregnant women

      CLINICAL INFECTIOUS DISEASES
    10. Blasi, E; Colombari, B; Mucci, A; Cossarizza, A; Radzioch, D; Boelaert, JR; Neglia, R
      Nramp1 gene affects selective early steps in macrophage-mediated anti-cryptococcal defense

      MEDICAL MICROBIOLOGY AND IMMUNOLOGY
    11. Boelaert, JR; Yaro, S; Augustijns, P; Meda, N; Schneider, YJ; Schols, D; Mols, R; De Laere, EA; Van de Perre, P
      Chloroquine accumulates in breast-milk cells: potential impact in the prophylaxis of postnatal mother-to-child transmission of HIV-1

      AIDS
    12. Simonart, T; Boelaert, JR; Van Vooren, JP; Heenen, M
      Iron and Kaposi's sarcoma

      ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
    13. Taramelli, D; Tognazioli, C; Ravagnani, F; Leopardi, O; Giannulis, G; Boelaert, JR
      Inhibition of intramacrophage growth of Penicillium marneffei by 4-aminoquinolines

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    14. Gangaidzo, IT; Moyo, VM; Mvundura, E; Aggrey, G; Murphree, NL; Khumalo, H; Saungweme, T; Kasvosve, I; Gomo, ZAR; Rouault, T; Boelaert, JR; Gordeuk, VR
      Association of pulmonary tuberculosis with increased dietary iron

      JOURNAL OF INFECTIOUS DISEASES
    15. Boelaert, JR; Sperber, K; Piette, J
      The additive in vitro anti-HIV-1 effect of chloroquine, when combined withzidovudine and hydroxyurea

      BIOCHEMICAL PHARMACOLOGY
    16. Boelaert, JR
      2nd International Conference on HIV and Iron March 31-April 1 2000, Brugge, Belgium - Abstracts

      JOURNAL OF CLINICAL VIROLOGY
    17. Kasvosve, I; Gomo, ZAR; Mvundura, E; Moyo, VM; Saungweme, T; Khumalo, H; Gordeuk, VR; Boelaert, JR; Delanghe, JR; De Bacquer, D; Gangaidzo, IT
      Haptoglobin polymorphism and mortality in patients with tuberculosis

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    18. Simonart, T; Van Vooren, JP; Parent, D; Heenen, M; Boelaert, JR
      Role of iron in dermatology

      DERMATOLOGY
    19. Simonart, T; Degraef, C; Andrei, G; Mosselmans, R; Hermans, P; Van Vooren, JP; Noel, JC; Boelaert, JR; Snoeck, R; Heenen, M
      Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    20. Schoonbroodt, S; Ferreira, V; Best-Belpomme, M; Boelaert, JR; Legrand-Poels, S; Korner, M; Piette, J
      Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of I kappa B alpha in NF-kappa B activation by an oxidative stress

      JOURNAL OF IMMUNOLOGY
    21. Taramelli, D; Brambilla, S; Sala, G; Bruccoleri, A; Tognazioli, C; Riviera-Uzielli, L; Boelaert, JR
      Effects of iron on extracellular and intracellular growth of Penicillium marneffei

      INFECTION AND IMMUNITY
    22. Bisti, S; Konidou, G; Papageorgiou, F; Milon, G; Boelaert, JR; Soteriadou, K
      The outcome of Leishmania major experimental infection in BALB/c mice can be modulated by exogenously delivered iron

      EUROPEAN JOURNAL OF IMMUNOLOGY
    23. Kasvosve, I; Delanghe, JR; Gomo, ZAR; Gangaidzo, IT; Khumalo, H; Wuyts, B; Mvundura, E; Saungweme, T; Moyo, VM; Boelaert, JR; Gordeuk, VR
      Transferrin polymorphism influences iron status in blacks

      CLINICAL CHEMISTRY
    24. Langlois, MR; Martin, ME; Boelaert, JR; Beaumont, C; Taes, YE; De Buyzere, ML; Bernard, DR; Neels, HM; Delanghe, JR
      The haptoglobin 2-2 phenotype affects serum markers of iron status in healthy males

      CLINICAL CHEMISTRY
    25. Kasvosve, I; Gomo, ZAR; Gangaidzo, IT; Mvundura, E; Saungweme, T; Moyo, VM; Khumalo, H; Boelaert, JR; Gordeuk, VR; Delanghe, JR
      Reference range of serum haptoglobin is haptoglobin phenotype-dependent inblacks

      CLINICA CHIMICA ACTA
    26. Boelaert, JR; Taramelli, D
      Untitled

      AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
    27. Boelaert, JR; Sperber, K; Piette, J
      Chloroquine exerts an additive in vitro anti-HIV type 1 effect when associated with didanosine and hydroxyurea

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    28. de Monye, C; Karcher, DS; Boelaert, JR; Gordeuk, VR
      Bone marrow macrophage iron grade and survival of HIV-seropositive patients

      AIDS
    29. Savarino, A; Pescarmona, GP; Boelaert, JR
      Iron metabolism and HIV infection: Reciprocal interactions with potentially harmful consequences?

      CELL BIOCHEMISTRY AND FUNCTION
    30. Saleppico, S; Boelaert, JR; Sale, FO; Mazzolla, R; Morucci, P; Bistoni, F; Blasi, E
      Differential effects of iron load on basal and interferon-gamma plus lipopolysaccharide enhance anticryptococcal activity by the murine microglial cell line BV-2

      JOURNAL OF NEUROIMMUNOLOGY
    31. Cantinieaux, B; Janssens, A; Boelaert, JR; Lejeune, M; Vermylen, C; Kerrels, V; Cornu, G; Winand, J; Fondu, P
      Ferritin-associated iron induces neutrophil dysfunction in hemosiderosis

      JOURNAL OF LABORATORY AND CLINICAL MEDICINE
    32. Boelaert, JR; Blasi, E
      Cryptococcosis and smoking: The potential role of iron

      JOURNAL OF INFECTIOUS DISEASES
    33. Simonart, T; Van Vooren, JP; Herbauts, J; Boelaert, JR
      Nigh incidence of Kaposi's sarcoma in Iceland and the Faroe Islands

      BRITISH JOURNAL OF CANCER
    34. Legssyer, R; Ward, RJ; Crichton, RR; Boelaert, JR
      Effect of chronic chloroquine administration on iron loading in the liver and reticuloendothelial system and on oxidative responses by the alveolar macrophages

      BIOCHEMICAL PHARMACOLOGY
    35. DELANGHE JR; LANGLOIS MR; BOELAERT JR; VANACKER J; VANWANZEELE F; VANDERGROEN G; HEMMER R; VERHOFSTEDE C; DEBUYZERE M; DEBACQUER D; ARENDT V; PLUM J
      HAPTOGLOBIN POLYMORPHISM, IRON-METABOLISM AND MORTALITY IN HIV-INFECTION

      AIDS
    36. BOELAERT JR; SPERBER K
      ANTIRETROVIRAL TREATMENT

      Lancet
    37. SIMONART T; NOEL JC; ANDREI G; PARENT D; VANVOOREN JP; HERMANS P; LUNARDIYSKANDAR Y; LAMBERT C; DIEYE T; FARBER CM; LIESNARD C; SNOECK R; HEENEN M; BOELAERT JR
      IRON AS A POTENTIAL COFACTOR IN THE PATHOGENESIS OF KAPOSIS-SARCOMA

      International journal of cancer
    38. ZHANG Y; CRICHTON RR; BOELAERT JR; JORENS PG; HERMAN AG; WARD RJ; LALLEMAND F; DEWITTE P
      DECREASED RELEASE OF NITRIC-OXIDE (NO) BY ALVEOLAR MACROPHAGES AFTER IN-VIVO LOADING OF RATS WITH EITHER IRON OR ETHANOL

      Biochemical pharmacology
    39. BOELAERT JR
      SERIES ON HOSPITAL INFECTIONS INTRODUCTION

      Acta Clinica Belgica
    40. BOELAERT JR; GORDEUK VR; PIETTE J; WEINBERG GA
      CONFERENCE REPORT - INTERNATIONAL-CONFERENCE ON HIV AND IRON, BRUGGE 1997

      TM & IH. Tropical medicine & international health
    41. SHATROV VA; BOELAERT JR; CHOUAIB S; DROGE W; LEHMANN V
      IRON CHELATION DECREASES HUMAN IMMUNODEFICIENCY VIRUS-1 TAT POTENTIATED TUMOR NECROSIS FACTOR-INDUCED NF-KAPPA-B ACTIVATION IN JURKAT CELLS

      European cytokine network
    42. MAZZOLLA R; BARLUZZI R; BROZZETTI A; BOELAERT JR; LUNA T; SALEPPICO S; BISTONI F; BLASI E
      ENHANCED RESISTANCE TO CRYPTOCOCCUS-NEOFORMANS INFECTION-INDUCED BY CHLOROQUINE IN A MURINE MODEL OF MENINGOENCEPHALITIS

      Antimicrobial agents and chemotherapy
    43. MENCACCI A; CENCI E; BOELAERT JR; BUCCI P; MOSCI P; DOSTIANI CF; BISTONI F; ROMANI L
      IRON OVERLOAD ALTERS INNATE AND T-HELPER CELL RESPONSES TO CANDIDA-ALBICANS IN MICE

      The Journal of infectious diseases
    44. COGLIATI M; ROVERSELLI A; BOELAERT JR; TARAMELLI D; LOMBARDI L; VIVIANI MA
      DEVELOPMENT OF AN IN-VITRO MACROPHAGE SYSTEM TO ASSESS PENICILLIUM-MARNEFFEI GROWTH AND SUSCEPTIBILITY TO NITRIC-OXIDE

      Infection and immunity
    45. LEGRANDPOELS S; MANIGLIA S; BOELAERT JR; PIETTE J
      ACTIVATION OF THE TRANSCRIPTION FACTOR NF-KAPPA-B IN LIPOPOLYSACCHARIDE-STIMULATED U937 CELLS

      Biochemical pharmacology
    46. BOELAERT JR; WEINBERG GA; WEINBERG ED
      ALTERED IRON-METABOLISM IN HIV-INFECTION - MECHANISMS, POSSIBLE CONSEQUENCES, AND PROPOSALS FOR MANAGEMENT

      Infectious agents and disease
    47. VANDENSAFFELE JK; BOELAERT JR
      ZYGOMYCOSIS IN HIV-POSITIVE PATIENTS - A REVIEW OF THE LITERATURE

      Mycoses
    48. BOELAERT JR; VANLANDUYT HW; GORDTS BZ; DEBAERE YA; MESSER SA; HERWALDT LA
      NASAL AND CUTANEOUS CARRIAGE OF STAPHYLOCOCCUS-AUREUS IN HEMODIALYSIS-PATIENTS - THE EFFECT OF NASAL MUPIROCIN

      Infection control and hospital epidemiology
    49. LIN SH; SHIEH SD; LIN YF; DEBRAUWER E; VANLANDUYT HW; GORDTS B; BOELAERT JR
      FATAL AEROMONAS-HYDROPHILA BACTEREMIA IN A HEMODIALYSIS PATIENT TREATED WITH DEFEROXAMINE

      American journal of kidney diseases
    50. WEINBERG GA; BOELAERT JR; SHANZER A
      MULTIPLE IRON CHELATORS OF DIVERSE CHEMICAL CLASSES ARE ACTIVE AGAINST PNEUMOCYSTIS-CARINII

      Pediatric research
    51. BOELAERT JR; PIETTE J; WEINBERG GA
      IRON AND OXIDATIVE STRESS AS A MECHANISM FOR THE ENHANCED PRODUCTION OF HUMAN-IMMUNODEFICIENCY-VIRUS BY ALVEOLAR MACROPHAGES FROM OTHERWISEHEALTHY CIGARETTE SMOKERS

      The Journal of infectious diseases
    52. SALEPPICO S; MAZZOLLA R; BOELAERT JR; PULITI M; BARLUZZI R; BISTONI F; BLASI E
      IRON REGULATES MICROGLIAL CELL-MEDIATED SECRETORY AND EFFECTOR FUNCTIONS

      Cellular immunology
    53. BOELAERT JR
      IRON AND INFECTION

      Acta Clinica Belgica
    54. BOELAERT JR; VANLANDUYT HW; DEBAERE YA; DERUYTER MM; DANEELS RF; SCHURGERS ML; MATTHYS EG; GORDTS BZ
      STAPHYLOCOCCUS-AUREUS INFECTIONS IN HEMODIALYSIS-PATIENTS - PATHOPHYSIOLOGY AND USE OF NASAL MUPIROCIN FOR PREVENTION

      Journal of chemotherapy
    55. BOELAERT JR; COLES GA; WENZEL RP; PITTET D
      UPDATE ON MUPIROCIN RESISTANCE - DISCUSSION

      Journal of chemotherapy
    56. SAPPEY C; BOELAERT JR; LEGRANDPOELS S; FORCEILLE C; FAVIER A; PIETTE J
      IRON CHELATION DECREASES NF-KAPPA-B AND HIV TYPE-1 ACTIVATION DUE TO OXIDATIVE STRESS

      AIDS research and human retroviruses
    57. NEWMAN SL; GOOTEE L; STROOBANT V; VANDERGOOT H; BOELAERT JR
      INHIBITION OF GROWTH OF HISTOPLASMA-CAPSULATUM YEAST-CELLS IN HUMAN MACROPHAGES BY THE IRON CHELATOR VUF-8514 AND COMPARISON OF VUF-8514 WITH DEFEROXAMINE

      Antimicrobial agents and chemotherapy
    58. JORENS PG; BOELAERT JR; HALLOY V; ZAMORA R; SCHNEIDER YJ; HERMAN AG
      HUMAN AND RAT MACROPHAGES MEDIATE FUNGISTATIC ACTIVITY AGAINST RHIZOPUS SPECIES DIFFERENTLY - IN-VITRO AND EX-VIVO STUDIES

      Infection and immunity
    59. SAPPEY C; BOELAERT JR; LEGRANDPOELS S; GRADY RW; PIETTE J
      NF-KAPPA-B TRANSCRIPTION FACTOR ACTIVATION BY HYDROGEN-PEROXIDE CAN BE DECREASED BY 2,3-DIHYDROXYBENZOIC ACID AND ITS ETHYL-ESTER DERIVATIVE

      Archives of biochemistry and biophysics
    60. BOELAERT JR
      STAPHYLOCOCCUS-AUREUS INFECTION IN HEMODIALYSIS-PATIENTS - MUPIROCIN AS A TOPICAL STRATEGY AGAINST NASAL CARRIAGE - A REVIEW

      Journal of chemotherapy
    61. ENA J; BOELAERT JR; BOYKEN LD; VANLANDUYT HW; GODARD CA; HERWALDT LA
      EPIDEMIOLOGY OF STAPHYLOCOCCUS-AUREUS INFECTIONS IN PATIENTS ON HEMODIALYSIS

      Infection control and hospital epidemiology
    62. EVANS RW; CROOK M; SANAKRALINGHAM A; NORMAN J; EXWORTHY T; BOELAERT JR
      SERUM-PROTEIN CELLULOSE-ACETATE ELECTROPHORESIS IN ALZHEIMERS-DISEASE

      Medical science research
    63. BOELAERT JR; VANLANDUYT HW; DEBAERE YA; GHEYLE DW; DANEELS RF; SCHURGERS ML; MATTHYS EG; GORDTS BZ
      EPIDEMIOLOGY AND PREVENTION OF STAPHYLOCO CCUS-AUREUS INFECTION IN HEMODIALYSIS

      Nephrologie
    64. BOELAERT JR; VANCUTSEM J; DELOCHT M; SCHNEIDER YJ; CRICHTON RR
      DEFEROXAMINE AUGMENTS GROWTH AND PATHOGENICITY OF RHIZOPUS, WHILE HYDROXYPYRIDINONE CHELATORS HAVE NO EFFECT

      Kidney international
    65. BOELAERT JR; DELOCHT M; SCHNEIDER YJ
      THE EFFECT OF DEFEROXAMINE ON DIFFERENT ZYGOMYCETES

      The Journal of infectious diseases
    66. DELOCHT M; BOELAERT JR; SCHNEIDER YJ
      IRON UPTAKE FROM FERRIOXAMINE AND FROM FERRIRHIZOFERRIN BY GERMINATING SPORES OF RHIZOPUS-MICROSPORUS

      Biochemical pharmacology
    67. VERDONCK AK; BOELAERT JR; GORDTS BZ; VANLANDUYT HW
      EFFECT OF FERRIOXAMINE ON THE GROWTH OF RHIZOPUS

      Mycoses
    68. BOELAERT JR; DELOCHT M
      SIDE-EFFECTS OF DESFERRIOXAMINE IN DIALYSIS PATIENTS

      Nephrology, dialysis, transplantation
    69. CANTINIEAUX B; BOELAERT JR; DEMEULENEIRE J; KERRELS V; FONDU P
      NEUTROPHILS FROM PATIENTS WITH SECONDARY HEMOSIDEROSIS CONTAIN EXCESSIVE AMOUNTS OF AUTOTOXIC IRON

      European journal of haematology
    70. BOELAERT JR; DELOCHT M; VANCUTSEM J; KERRELS V; CANTINIEAUX B; VERDONCK A; VANLANDUYT HW; SCHNEIDER YJ
      MUCORMYCOSIS DURING DEFEROXAMINE THERAPY IS A SIDEROPHORE-MEDIATED INFECTION - INVITRO AND INVIVO ANIMAL STUDIES

      The Journal of clinical investigation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 21:20:21